Neuca

Neuca Days Inventory Outstanding

The Days Inventory Outstanding (DIO) of Neuca (NEU.WA) as of Nov 7, 2026 is 58.18. In the previous year, Days Inventory Outstanding (DIO) was 52.35 — a change of 11.14% (higher).

Days Inventory Outstanding

58.18

YoY

11.14%

Last updated:

Days Inventory Outstanding (DIO) of Neuca is 2025 58.18 . Days Inventory Outstanding (DIO) of Neuca was 2024 52.35 . It decreases by 11.14% higher compared to the previous year.

The Neuca Days Inventory Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Days Inventory Outstanding
Date
Days Inventory Outstanding
Jan 1, 2018
56.64 PLN
Jan 1, 2019
51.16 PLN
Jan 1, 2020
52.44 PLN
Jan 1, 2021
49.24 PLN
Jan 1, 2022
47.39 PLN
Jan 1, 2023
52.44 PLN
Jan 1, 2024
52.35 PLN
Jan 1, 2025
58.18 PLN
The Neuca Days Inventory Outstanding history
YEARDays Inventory OutstandingYoY
58.18+11.14%
52.35-0.17%
52.44+10.65%
47.39-3.76%
49.24-6.10%
52.44+2.51%
51.16-9.69%
56.64+2.09%
55.49+2.25%
54.27-14.00%
63.10-1.20%
63.87—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Neuca Stock analysis

What does Neuca do? NEUCA SA generates revenue through the wholesale distribution of pharmaceutical products to pharmacies, leveraging its extensive network in the health market. The company also produces and sells its own branded drugs, supplements, and cosmetics, while offering clinical trials, telemedicine services, and IT solutions tailored for healthcare providers. Its e-commerce platform further supports the healthcare industry by enabling digital transactions for medical products and services. The primary buyers include pharmacies, healthcare institutions, and consumers seeking health-related products through online channels. NEUCA SA's business model integrates multiple revenue streams within the health sector, with a focus on both physical and digital distribution. The firm's own-brand products, such as pharmaceuticals and cosmetics, are sold directly to end-users and retail partners, while its IT solutions and telemedicine services target healthcare organizations. Clinical trials represent another key segment, attracting partnerships with research institutions and pharmaceutical firms. The company's operational scope spans from production to distribution, ensuring a comprehensive approach to healthcare market needs. The company's revenue is driven by its diversified portfolio, including drug distribution, branded product sales, and specialized services like telemedicine and clinical trials. Pharmacies remain the core customer segment for its wholesale operations, while e-commerce and IT solutions cater to a broader audience of healthcare providers and consumers. NEUCA SA's strategic positioning in the health market allows it to capitalize on multiple growth areas without relying on a single revenue source. Neuca is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Neuca stock

Days Inventory Outstanding (DIO) of Neuca is 58.18 in 2025.

Days Inventory Outstanding (DIO) of Neuca changed from 52.35 to 58.18, representing a 11.14% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Days Inventory Outstanding (DIO) Neuca since 2006 – with annual values, charts, and detailed analysis.

DIO measures the average number of days inventory is held before being sold. Lower values indicate more efficient inventory management.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Days Inventory Outstanding (DIO)'s Neuca with sector peers and the industry average to assess whether it is attractive.

To evaluate Days Inventory Outstanding (DIO)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Days Inventory Outstanding (DIO).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Neuca

All Key Metrics — Neuca